OTC External Analgesics - US


October 1, 2011
124 Pages - SKU: GN6665429
License type:
Countries covered: United States

Mintel’s exclusive consumer research and its analysis of market drivers suggest there is significant opportunity for products formulated for specific conditions.

Arthritis: The prevalence of arthritis has been steadily increasing, from some 35 million adults in 1985, to 46 million in 2003/05, to 50 million in 2007/09, according to the CDC. This number is expected to grow to 67 million by 2030. Mintel’s exclusive consumer research in this report finds that 32% of respondents who use OTC external analgesics use them to treat pain from arthritis.




More Over-the-Counter Drugs reports by Mintel International Group Ltd.

Cold, Flu and Allergy Remedies - US - April 2013 by Mintel International Group Ltd.
“While sales of OTC cold, flu, and allergy products have increased, the category faces several challenges, such as sales of private label brands as ...
Homeopathic and Herbal Remedies - US - March 2013 by Mintel International Group Ltd.
“Though sales of homeopathic and herbal remedies continue to increase, the market is up against several challenges. This includes low awareness among consumers, limited ...
Black Consumers' Diet and Wellness - US - March 2013 by Mintel International Group Ltd.
Black consumers exhibit the highest incidence of obesity and related diseases, but they are doing little to address it. Cultural as well as economic elements ...
Smoking Cessation Products - US - December 2012 by Mintel International Group Ltd.
Sales of smoking cessation products are expected to continue to experience growth. However, growth is limited as the market faces many challenges, such as domination ...
See all reports like this >>

More United States Over-the-Counter Drugs reports

Health Supplement Stores by First Research, Inc.
Health Supplement StoresBrief Excerpt from Industry Overview Chapter:Companies in this industry primarily sell vitamins, minerals, and dietary supplements. Major US companies include GNC, Vitamin World, ...
Brand Name Pharmaceutical Manufacturing in the US - Industry Risk Rating Report by IBISWorld
Industry Risk Ratings SynopsisThis Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Brand Name Pharmaceutical Manufacturing in the US industry. ...
Cough, Cold and Allergy (Hay Fever) Remedies in the US by Euromonitor International
Executive Summary TRENDS Cough, cold and allergy (hay fever) remedies faced several challenges in 2012. First, the 2011-2012 flu season was unusually mild. Warmer ...
Cold, Flu and Allergy Remedies - US - April 2013 by Mintel International Group Ltd.
“While sales of OTC cold, flu, and allergy products have increased, the category faces several challenges, such as sales of private label brands as ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!